Nxera Pharma Co., Ltd. (TYO:4565)
Japan · Delayed Price · Currency is JPY 1,363.00
+20.00 (1.49%)
Oct 26, 2026, 3:30 PM JST
Nxera Pharma Market Cap
Nxera Pharma has a market cap or net worth of 124.55 billion as of October 26, 2026. It is the 11,434th most valuable company in the world and the 872nd biggest in Japan. Its market cap has increased by 42.62% in one year.
Market Cap
124.55B
Enterprise Value
161.20B
Revenue
33.43B
Global Rank
Country Rank
#872 Japan
PE Ratio
n/a
ChartMarket Cap Chart
Since July 29, 2004, Nxera Pharma's market cap has increased from 38.40B to 124.55B, an increase of 224.37%. That is a compound annual growth rate of 5.43%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 26, 2026 | 124.55B | 66.42% |
| Dec 30, 2025 | 74.84B | -20.57% |
| Dec 30, 2024 | 94.22B | -25.87% |
| Dec 29, 2023 | 127.10B | -27.43% |
| Dec 30, 2022 | 175.15B | 12.85% |
| Dec 30, 2021 | 155.21B | 7.00% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| GNI Group | 177.10B |
| Oncolys BioPharma | 174.85B |
| PeptiDream | 136.22B |
| SanBio Company | 72.13B |
| Heartseed | 61.31B |
| Cuorips | 57.37B |
| 3-D Matrix | 46.46B |
| Healios K.K. | 36.33B |